THC vs UHS
Tenet Healthcare Corp. and Universal Health Services Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | THC | UHS |
|---|---|---|
| Revenue | $21.3B | $17.4B |
| Net income | $2.4B | $1.5B |
| Gross margin | · | · |
| Net margin | 11.1% | 8.7% |
| Return on equity | · | 21.4% |
| Diluted EPS | $15.49 | $23.10 |
| Dividend / share | · | $0.80 |
| Payout ratio | · | 3.4% |
| Free cash flow | $2.5B | $849.2M |
| Equity | $4.2B | $7.3B |
| Net debt / equity | 2.42× | 0.63× |
| Current ratio | 1.76× | 1.05× |
| Revenue CAGR 5y | 3.9% | 8.5% |
| Profit CAGR 5y | 25.2% | 9.5% |
THC bills 1.2× the revenue of UHS, and keeps more of each dollar of revenue as profit (11.1% against 8.7%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | THC | UHS |
|---|---|---|
| FY2025 | $21.3B | $17.4B |
| FY2024 | $20.7B | $15.8B |
| FY2023 | $20.6B | $14.3B |
| FY2022 | $19.2B | $13.4B |
| FY2021 | $19.5B | $12.6B |
| FY2020 | $17.6B | $11.6B |
| FY2019 | $18.5B | $11.4B |
| FY2018 | $18.3B | $10.8B |
| FY2017 | $20.6B | $10.4B |
| FY2016 | $21.1B | $9.8B |
Bottom line
| Fiscal year | THC | UHS |
|---|---|---|
| FY2025 | $2.4B | $1.5B |
| FY2024 | $4.1B | $1.1B |
| FY2023 | $1.3B | $717.8M |
| FY2022 | $1.0B | $675.6M |
| FY2021 | $1.5B | $991.6M |
| FY2020 | $768.0M | $944.0M |
| FY2019 | $171.0M | $814.9M |
| FY2018 | $459.0M | $779.7M |
| FY2017 | $-320.0M | $752.3M |
| FY2016 | $176.0M | $702.4M |
18 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$3,945,171,000 | THC |
| FY2024 | +$4,847,065,000 | THC |
| FY2023 | +$6,282,024,000 | THC |
| FY2022 | +$5,774,630,000 | THC |
| FY2021 | +$6,842,883,000 | THC |
| FY2020 | +$6,081,103,000 | THC |
| FY2019 | +$7,100,741,000 | THC |
| FY2018 | +$7,540,722,000 | THC |
| FY2017 | +$10,203,135,000 | THC |
| FY2016 | +$11,303,790,000 | THC |
| FY2015 | +$11,067,549,000 | THC |
| FY2014 | +$9,702,912,000 | THC |
| FY2013 | +$4,691,127,000 | THC |
| FY2012 | +$2,942,600,000 | THC |
| FY2011 | +$1,893,778,000 | THC |
| FY2010 | +$3,364,853,000 | THC |
| FY2009 | +$3,115,621,000 | THC |
| FY2008 | +$3,562,583,000 | THC |
THC has reported the higher revenue in every one of these 18 fiscal years. The gap has widened since the earliest year compared.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.
18 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +2.4 pp | THC |
| FY2024 | +12.3 pp | THC |
| FY2023 | +1.3 pp | THC |
| FY2022 | +0.3 pp | THC |
| FY2021 | −0.2 pp | UHS |
| FY2020 | −3.9 pp | UHS |
| FY2019 | −6.3 pp | UHS |
| FY2018 | −4.9 pp | UHS |
| FY2017 | −9.0 pp | UHS |
| FY2016 | −6.8 pp | UHS |
| FY2015 | −7.9 pp | UHS |
| FY2014 | −6.9 pp | UHS |
| FY2013 | −8.4 pp | UHS |
| FY2012 | −5.7 pp | UHS |
| FY2011 | −5.6 pp | UHS |
| FY2010 | +8.3 pp | THC |
| FY2009 | −3.5 pp | UHS |
| FY2008 | −4.4 pp | UHS |
The higher net margin has changed hands between THC and UHS over this period.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
THC's net margin has been more volatile than UHS's over the 18 comparable fiscal years — 5.5 percentage points of standard deviation against 1.2.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between THC and UHS over these 18 fiscal years — THC led in 5 and UHS in 13.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
THC's return on equity has been more volatile than UHS's over the 3 comparable fiscal years — 31.2 percentage points of standard deviation against 1.5.
3 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
THC led in return on equity in every one of the 3 comparable fiscal years — a structural lead, not a recent swing.
3 of 18 comparable fiscal years — a year missing data on either side is not counted.